Volansi Tests Drone Delivery Of Cold-Chain Medicines

Bill Carey October 20, 2020
VOLY
Voly C10 hybrid drone.
Credit: Volansi
U.S. drone start-up Volansi announced on Oct. 20 that it is testing the delivery of temperature-controlled medicines in North Carolina with pharmaceutical company Merck. Volansi is deploying its Voly C10 hybrid fixed-wing vertical-takeoff-and-landing (VTOL) unmanned aircraft to transport “cold chain...
Bill Carey

Bill covers business aviation and advanced air mobility for Aviation Week Network. A former newspaper reporter, he has also covered the airline industry, military aviation, commercial space and uncrewed aircraft systems. He is the author of 'Enter The Drones, The FAA and UAVs in America,' published in 2016.

Subscription Required

 

Volansi Tests Drone Delivery Of Cold-Chain Medicines is published in Aerospace Daily & Defense Report, an Aviation Week Intelligence Network (AWIN) Market Briefing and is included with your AWIN membership.

Already a member of AWIN or subscribe to Aerospace Daily & Defense Report through your company? Login with your existing email and password.

Not a member?  Learn how you can access the market intelligence and data you need to stay abreast of what's happening in the aerospace and defense community.

LoginLearn How

Related Content

Voly
Dronemaker Volansi Wins $50M In Venture Financing
Whisper Tests Quiet Electric Ducted Fan On Modified Glider
Michigan Funds Projects To Build AAM Infrastructure
Australia Leads Wing’s Latest Drone Delivery Expansion
Electra’s Goldfinch Completes Off-Runway Testing
Aviation Week Intelligence Network
Monitor the market and connect your business to the people, programs and proprietary data driving the Aerospace & Defense market - only available with AWIN.

ASD_AWIN_thumbnail_270

Stay Connected.
Stay Informed
Grow Your Business.

Learn How